Saturday, November 15, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

PNE Stock: Wind Woes Widen Losses Despite Revenue Growth

Andreas Sommer by Andreas Sommer
August 14, 2025
in Stocks
0
PNE Stock
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

German wind energy company PNE reported mixed first-half results, with revenues climbing over 20% to €73.9 million but net losses deepening to €30.5 million, up from €20 million a year earlier. Weak wind conditions in early 2024 severely impacted earnings, dragging EBITDA down to €4.7 million—nearly half of the prior year’s figure. While operational performance improved in Q2, it couldn’t offset the sluggish start. The company highlighted progress in its project pipeline, commissioning four new wind farms and securing permits for 489 MW of capacity, bolstering its owned portfolio to 491 MW.

Turnaround Hinges on Project Sales

Management remains optimistic, banking on imminent deals to salvage annual targets. Recent sales in France and Germany totaling 48.4 MW mark the start of a broader divestment push, with additional transactions planned in Poland and Germany. PNE reaffirmed its full-year EBITDA guidance of €70–110 million, contingent on these sales. Investors appeared unfazed by the losses, with shares holding steady around €14.60. The coming months will test whether PNE’s project pipeline can outweigh nature’s unpredictability.

Ad

PNE Stock: Buy or Sell?! New PNE Analysis from November 15 delivers the answer:

The latest PNE figures speak for themselves: Urgent action needed for PNE investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 15.

PNE: Buy or sell? Read more here...

Tags: PNE
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
MUT Stock

MUT Stock: Sharp Downgrade Amid Q2 Nightmare

Lanxess Stock

Lanxess Stock: Drastic Cuts Amid Market Turmoil

Lenovo Stock

Lenovo Stock: Record Profits, Sharp Decline

Recommended

Technology Blockchain Markets and money

Analyst Ratings and Price Targets for KLA NASDAQ KLAC

2 years ago
BigBearai Holdings Stock

BigBear.ai Stock: Can Government Contracts Offset Financial Headwinds?

1 month ago
Emerson Electric Stock

Emerson Electric Positions Itself for Lithium-Driven Growth

2 days ago
Alibaba Stock

Alibaba Shares Face Divergent Analyst Views Amid Strategic AI Partnership

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Chip Sector Showdown: AMD’s AI Surge Versus Intel’s Turnaround Bid

Cloudflare Positions for AI Leadership with Strategic Data Initiative

Marvell Technology Shares Face Mounting Pressure

Vertex’s Billion-Dollar Bet on Alpine Immune Sciences: A Strategic Analysis

WiMi Unveils Quantum AI Breakthrough for Holographic Imaging

iSun’s Final Chapter: Liquidation Wipes Out Shareholder Value

Trending

Tesla Stock
Analysis

Tesla’s Strategic Pivot: Supply Chain Overhaul Amid Executive Departures

by Robert Sasse
November 15, 2025
0

Tesla has initiated one of its most significant operational shifts by instructing suppliers to eliminate all China-manufactured...

Phathom Pharmaceuticals Stock

Phathom Pharmaceuticals Stock Surges on Strong Quarterly Performance

November 15, 2025
Verve Therapeutics Stock

Verve Therapeutics Acquisition Marks New Chapter in Gene Editing

November 15, 2025
Intel Stock

Chip Sector Showdown: AMD’s AI Surge Versus Intel’s Turnaround Bid

November 15, 2025
Cloudflare Stock

Cloudflare Positions for AI Leadership with Strategic Data Initiative

November 15, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Strategic Pivot: Supply Chain Overhaul Amid Executive Departures
  • Phathom Pharmaceuticals Stock Surges on Strong Quarterly Performance
  • Verve Therapeutics Acquisition Marks New Chapter in Gene Editing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com